| Pharmaceutical active ingredients: |
| Oxybuprocaine Hydrochloride |
| Available forms, composition and doses of Oxybuprocaine SDU Faure: |
| Drops; Ophthalmic; Oxybuprocaine Hydrochloride 0.4% |
| Oxybuprocaine SDU Faure medical category: |
| Human:Local anesthetics |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| D04AB03 - OxybuprocaineS01HA02 - Oxybuprocaine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Thea Laboratoires |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Novesinol | Oxybuprocaine Hydrochloride | Novartis |
| Oftalmocaina | Oxybuprocaine Hydrochloride | Allergan |
| Oftan Obucain | Oxybuprocaine Hydrochloride | Santen Pharmaceutical |
| Oxbarukain | Oxybuprocaine Hydrochloride | Chauvin Ankerpharm |
| Oxinest | Oxybuprocaine Hydrochloride | Latinofarma Indistrias Farmaceuticas |
| Prescaina | Oxybuprocaine Hydrochloride | Llorens |
| Unicaine | Oxybuprocaine Hydrochloride | Bournonville Eumedica |
| Vesiform S | Oxybuprocaine Hydrochloride | Novartis |
| Anestesi Doble | Oxybuprocaine Hydrochloride; Tetracaine Hydrochloride | Alcon |
| Anesthesique Double | Oxybuprocaine Hydrochloride; Tetracaine Hydrochloride | Sanofi-Aventis |